Atrial Fibrillation and Prevention of Embolic Stroke
نویسندگان
چکیده
منابع مشابه
Embolic Stroke, Atrial Fibrillation, and Microbleeds
Patients with AF have a high risk of ischemic stroke, which can be dramatically reduced by oral anticoagulation with vitamin K antagonists (VKAs). I will look at our patient from different positions. First, the patient has paroxysmal AF. The type of AF (paroxysmal, persistent, or permanent) has only a minor impact on the stroke risk. All types of AF respond to oral anticoagulation with VKAs or ...
متن کاملStroke prevention in Atrial Fibrillation.
Atrial fibrillation is found in a third of all ischaemic strokes, even more after post-stroke atrial fibrillation monitoring. Data from stroke registries show that both unknown and untreated or under treated atrial fibrillation is responsible for most of these strokes, which are often fatal or debilitating. Most could be prevented if efforts were directed towards detection of atrial fibrillatio...
متن کاملStroke Prevention in Atrial Fibrillation.
Non-valvular atrial fibrillation is a common and from a neurological perspective the most significant cardiac arrhythmia with a growing world-wide incidence. It also carries a significant associated morbidity and mortality, with cardioembolic strokes arguably being the most disabling sequelae. This brief review will highlight the important studies and the latest treatment modalities available f...
متن کاملAtrial fibrillation 1 Stroke prevention in atrial fibrillation
Atrial fibrillation is found in a third of all ischaemic strokes, even more after post-stroke atrial fibrillation monitoring. Data from stroke registries show that both unknown and untreated or under treated atrial fibrillation is responsible for most of these strokes, which are often fatal or debilitating. Most could be prevented if efforts were directed towards detection of atrial fibrillatio...
متن کاملDabigatran for stroke prevention in atrial fibrillation.
Dabigatran is a novel direct thrombin inhibitor that has recently been approved for primary and secondary stroke prevention and prevention of systemic embolism in patients with atrial fibrillation. In the pivotal RE-LY study, dabigatran 110 mg BID was demonstrated to be associated with a stroke rate similar to that observed with warfarin (INR target 2.0 to 3.0), but with a lower rate of major h...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Stroke
سال: 2021
ISSN: 0039-2499,1524-4628
DOI: 10.1161/strokeaha.120.030420